Reviews
Systematic reviews
Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.
88 reviews, newest first
Addition of anti‐leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma
Cochraneheadline outcomes only
18 findings
Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery
Cochraneheadline outcomes only
14 findings
Stepping down the dose of inhaled corticosteroids for adults with asthma
Cochraneheadline outcomes only
14 findings
Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery)
Cochraneheadline outcomes only
5 findings
Corticosteroids for Guillain‐Barré syndrome
Cochraneheadline outcomes only
7 findings
Corticosteroids for Bell's palsy (idiopathic facial paralysis)
Cochraneheadline outcomes only
4 findings
Corticosteroids for managing tuberculous meningitis
Cochraneheadline outcomes only
2 findings
Corticosteroids for the treatment of Duchenne muscular dystrophy
Cochraneheadline outcomes only
23 findings
Corticosteroids for treating nerve damage in leprosy
Cochraneheadline outcomes only
13 findings
Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta₂‐agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
Cochraneheadline outcomes only
7 findings
Corticosteroids for acute bacterial meningitis
Cochraneheadline outcomes only
5 findings
Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms
Cochraneheadline outcomes only
1 finding
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection
Cochraneheadline outcomes only
4 findings
Safety of topical corticosteroids in pregnancy
Cochraneheadline outcomes only
19 findings
Addition of long‐acting beta₂‐agonists to inhaled corticosteroids for chronic asthma in children
Cochraneheadline outcomes only
14 findings
Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis
Cochraneheadline outcomes only
4 findings
Corticosteroids for the management of cancer‐related pain in adults
Cochraneheadline outcomes only
1 finding
Stopping long‐acting beta₂‐agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
Cochraneheadline outcomes only
7 findings
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta₂‐agonists (LABA) for adults with asthma
Cochraneheadline outcomes only
7 findings
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Cochraneheadline outcomes only
13 findings
Addition to inhaled corticosteroids of long‐acting beta₂‐agonists versus anti‐leukotrienes for chronic asthma
Cochraneheadline outcomes only
7 findings
Corticosteroids for dengue infection
Cochraneheadline outcomes only
11 findings
Systemic corticosteroids for acute sinusitis
Cochraneheadline outcomes only
7 findings